|
Dear Colleagues -- You will recall that FDA has previously issued public statements noting the agency's concerns with highly concentrated caffeine products -- whether powder or liquid. In response, UNPA has issued two no-sale policy statements, following FDA's public statements. Today FDA has begun issuing warning letters to companies selling high concentration caffeine products. See press announcement here. This confirms the agency is serious about this issue, and we remind our members of the importance of abiding by our no-sale policy which, to our knowledge, all members currently respect.
I should note that Steve Tave made very favorable mention of UNPA's no-sale policies for high caffeine products during our recent retreat and noted his appreciation for our leadership on this specific issue. Cordially, LDI Comments are closed.
|